3,4-dihydroxyphenylacetic acid has been researched along with biperiden in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andia, I; Davila, R; Retuerto, F; Zamalloa, I; Zumarraga, M | 1 |
1 other study(ies) available for 3,4-dihydroxyphenylacetic acid and biperiden
| Article | Year |
|---|---|
Chronic neuroleptic treatment does not suppress the dynamic characteristics of the dopaminergic receptor D2 system.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Biperiden; Brain Chemistry; Chromatography, High Pressure Liquid; Dopamine; Electrochemistry; Haloperidol; Homovanillic Acid; Male; Neostriatum; Olfactory Bulb; Parasympatholytics; Rats; Rats, Wistar; Receptors, Dopamine D2 | 1994 |